share_log

4: Statement of changes in beneficial ownership of securities-Director Charles Faith L.

4: Statement of changes in beneficial ownership of securities-Director Charles Faith L.

4：持股变动声明-董事 Charles Faith L.
美股SEC公告 ·  2024/12/20 16:10

Moomoo AI 已提取核心信息

Charles Faith L., associated with Conduit Pharmaceuticals, has reported a future transaction scheduled for 12/18/2024. The nature and details of this transaction are not specified in the current disclosure.The reporting person's address is listed as 4851 Tamiami Trail North, Suite 200, Naples, FL, 34103. While the announcement indicates a planned action, it does not provide information on the type of securities involved, the quantity, or the transaction's value.Investors should note that this is a forward-looking report and the actual transaction may be subject to change. The lack of specific details in the current disclosure limits the ability to assess the potential impact on the company's stock or Faith's position within Conduit Pharmaceuticals.
Charles Faith L., associated with Conduit Pharmaceuticals, has reported a future transaction scheduled for 12/18/2024. The nature and details of this transaction are not specified in the current disclosure.The reporting person's address is listed as 4851 Tamiami Trail North, Suite 200, Naples, FL, 34103. While the announcement indicates a planned action, it does not provide information on the type of securities involved, the quantity, or the transaction's value.Investors should note that this is a forward-looking report and the actual transaction may be subject to change. The lack of specific details in the current disclosure limits the ability to assess the potential impact on the company's stock or Faith's position within Conduit Pharmaceuticals.
Charles Faith L.，与Conduit Pharmaceuticals相关，已报告预计在2024年12月18日进行一笔交易。此次交易的性质和细节在当前披露中未作说明。报告人的地址列为佛罗里达州那不勒斯市塔米亚米小道北4851号，200室，邮政编码34103。虽然公告表明了一个计划行动，但并没有提供涉及的证券类型、数量或交易价值的信息。投资者应注意，这是一个前瞻性报告，实际交易可能会有所变化。当前披露中缺乏具体细节限制了评估对公司股票或Faith在Conduit Pharmaceuticals内地位的潜在影响的能力。
Charles Faith L.，与Conduit Pharmaceuticals相关，已报告预计在2024年12月18日进行一笔交易。此次交易的性质和细节在当前披露中未作说明。报告人的地址列为佛罗里达州那不勒斯市塔米亚米小道北4851号，200室，邮政编码34103。虽然公告表明了一个计划行动，但并没有提供涉及的证券类型、数量或交易价值的信息。投资者应注意，这是一个前瞻性报告，实际交易可能会有所变化。当前披露中缺乏具体细节限制了评估对公司股票或Faith在Conduit Pharmaceuticals内地位的潜在影响的能力。
有用
没用

该公告为独立文件：

独立文件1  查看翻译

声明：本内容仅用作提供资讯及教育之目的，不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    热议
    美股
    股票代码最新价涨跌幅

    暂无数据

    资讯热榜
    更新时间